| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-12 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 2e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.27 | 2e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |